915107-47-0

Basic information

• Product Name: (6-chloro-5-methoxypyridin-3-yl)methanol
• CAS NO: 915107-47-0
• Molecular Weight: 173.599
• Mol File: 915107-47-0.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: (6-chloro-5-methoxypyridin-3-yl)methanol(CAS DataBase Reference)
• NIST Chemistry Reference: (6-chloro-5-methoxypyridin-3-yl)methanol(915107-47-0)
• EPA Substance Registry System: (6-chloro-5-methoxypyridin-3-yl)methanol(915107-47-0)

Safety Data

• Hazardous Substances Data: 915107-47-0(Hazardous Substances Data)

Usage

General Description

(6-chloro-5-methoxypyridin-3-yl)methanol is an organic compound with the chemical formula C7H8ClNO2. It is a pyridine derivative that contains a chloro and a methoxy functional group, as well as a hydroxymethyl group attached to the pyridine ring. (6-chloro-5-methoxypyridin-3-yl)methanol is often used as an intermediate in the synthesis of pharmaceuticals and agrochemicals, and it has potential applications in the development of new drugs or pesticides. It is important to handle this compound with care, as it may be toxic or harmful if ingested or inhaled, and appropriate safety precautions should be taken when working with it in a laboratory or industrial setting.

Upstream product

• 915107-30-1 methyl 6-chloro-5-hydroxypyridine-3-carboxylate 
• 30766-22-4 methyl 5-hydroxy-3-pyridinecarboxylate 
• 915107-31-2 methyl 6-chloro-5-methoxypyridine-3-carboxylate 
• 915107-39-0 6-chloro-5-methoxynicotinic acid 

Downstream Products

• 380912-09-4 5-hydroxy imidacloprid 

Relevant articles and documents

Synthesis method of imidacloprid metabolite 5-hydroxyimidacloprid

The invention discloses a synthesis method of an imidacloprid metabolite 5-hydroxyimidacloprid, and belongs to the field of medicine synthesis. According to the synthesis method, methyl 5-hydroxynicotinate is used as a raw material, synthesis of the imidacloprid metabolite 5-hydroxylimidacloprid is achieved for the first time through six-step reaction, an optimal synthesis route and reaction conditions are screened out through a large number of experiments, the purity of the prepared target product can reach 99% or above, and the target product does not contain raw material medicine imidacloprid can be used for research on pharmacokinetics, raw material medicine impurity identification, environment control and protection and the like, provides a sample for impurity identification of imidacloprid, metabolic mechanism research, influence on the environment after medicine use, how to carry out corresponding protection and the like, and has important application value.

HETEROCYCLIC DERIVATES

The present invention provides compounds of formula (I): compositions comprising such compounds; the use of such compounds in therapy (for example in the treatment or prevention of a disease or condition in which plasma kallikrein activity is implicated); and methods of treating patients with such compounds; wherein R5, R6, R7, A, B,W, X, Y and Z are as defined herein.